![]() |
市場調查報告書
商品編碼
1654306
美國眼部護理市場規模、佔有率、趨勢分析報告:按產品、購買類型、分銷管道、細分預測,2025-2030 年U.S. Eye Care Market Size, Share & Trends Analysis Report By Product (Contact Lens, Ocular Health Products), By Mode Of Purchase (Over The Counter, Prescribed), By Distribution Channel, By Country, And Segment Forecasts, 2025 - 2030 |
預計到 2024 年,美國眼保健市場價值將達到 273 億美元,預計從 2025 年到 2030 年,複合年成長率將達到 7.1%,這主要得益於近視、青光眼和白內障等視力障礙盛行率的上升。
社會老化加劇,65歲以上成年人口超過5,400萬,對眼部保健服務及產品的需求也隨之增加。微創手術設備和先進的診斷工具等技術進步正在改善治療效果。人們對預防性眼部護理意識的增強和數位設備的普及推動了對藍光阻擋鏡片等解決方案的需求。強大的醫療保健基礎設施以及對眼科研究和創新的大力投資進一步支持了美國市場。
2023 年 9 月,博士倫推出了 Lumify Eye Illuminations 系列,其中包括膠束清潔水、睫毛和眉毛精華液以及 HydraGel 亮白霜等低過敏性產品。該系列產品與眼科醫生和皮膚科醫生合作開發,將安全放在首位,已有超過 15,000 次使用證明這一點。這些產品不含苯甲酸酯類、硫酸鹽和酒精等刺激性化學物質,滿足了日益成長的消費者對溫和而有效的眼部護理解決方案的偏好。
美國眼保健市場的另一個顯著發展是 Iridex 推出其下一代雷射 Iridex 532 和 Iridex 577。這些先進的平台是在該公司成立 35 週年之際推出的,採用了專利的微脈衝技術,並提供多種治療模式來治療視網膜疾病和青光眼。這些雷射具有直覺的觸控螢幕介面,可增強臨床控制並提高治療精度。此公告是在 2024 年夏威夷眼科與視網膜會議召開之前發布的,凸顯了 Iridex 對創新的承諾以及為全球眼科醫生提供可靠雷射系統的傳統。 Iridex 總裁兼執行長 Bruce 表示,這些雷射代表著將尖端技術與以用戶為中心的設計相結合的關鍵進步,可以最佳化患者照護。
此外,微創手術設備和個人化護理等診斷工具和治療方案的進步正在改變眼科護理模式。消費者對同時滿足功能性和美觀性的產品的需求也在塑造市場趨勢。例如,Lumify Eye Illuminations 等低過敏性、營養豐富的產品滿足了人們對有效且溫和的解決方案日益成長的偏好。
The U.S. eye care market size was estimated at USD 27.3 billion in 2024 and is expected to grow at a CAGR of 7.1% from 2025 to 2030, driven by a rising prevalence of vision disorders such as myopia, glaucoma, and cataracts. An aging population, with over 54 million adults aged 65 and older, contributes to increased demand for eye care services and products. Technological advancements, including minimally invasive surgical devices and advanced diagnostic tools, are enhancing treatment outcomes. Growing awareness of preventive eye care and the increasing adoption of digital devices are fueling demand for solutions like blue-light-blocking lenses. The U.S. market is further supported by robust healthcare infrastructure and strong investments in ophthalmic research and innovation.
In September 2023, Bausch + Lomb launched its Lumify Eye Illuminations line, featuring hypoallergenic products such as micellar cleansing water, lash and brow serum, and hydra-gel brightening cream. Developed with ophthalmologists and dermatologists, the line prioritizes safety, as demonstrated in over 15,000 applications. Free from harsh chemicals such as parabens, sulfates, and alcohol, these products address growing consumer preferences for gentle, effective eye care solutions.
Another notable development in the U.S. eye care market is the introduction of Iridex Corp's next-generation Iridex 532 and Iridex 577 lasers. Launched in conjunction with the company's 35th anniversary, these advanced platforms incorporate patented MicroPulse Technology and offer multiple treatment modes to address retinal disorders and glaucoma. Featuring an intuitive touchscreen interface, these lasers enhance clinical control and improve treatment precision. The announcement was made ahead of the Hawaiian Eye and Retina 2024 meeting, underscoring Iridex's commitment to innovation and its legacy of providing reliable laser systems to ophthalmologists worldwide. According to David Bruce, President and CEO of Iridex, these lasers represent a pivotal step forward, combining cutting-edge technology with user-centric design to optimize patient care.
In addition, advancements in diagnostic tools and treatment options, such as minimally invasive surgical devices and personalized therapies, are transforming the landscape of eye care. Consumer demand for products that address both functional and cosmetic needs is also shaping market trends. For instance, hypoallergenic and nutrient-enriched products, such as Lumify Eye Illuminations, cater to the growing preference for solutions that are both effective and gentle.
U.S. Eye Care Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. eye care market report based on product, mode of purchase, and distribution channel: